&nbsp;

Nov 2024

Drug

chlorambucil

Other Name(s): Leukeran®

Quick Link(s):

Nov 2024

Drug

busulfan

Other Name(s): Busulfex® , Myleran®

Quick Link(s):

Drug Monograph

Dec 1969

Drug

capecitabine

Other Name(s): Xeloda®

Quick Link(s):

Jul 2024

Drug

bicalutamide

Other Name(s): Casodex® (multiple brands available)

Quick Link(s):

Nov 2017

Drug

cyclophosphamide

Other Name(s): Procytox®

Quick Link(s):

Dec 1969

Regimen

BICA

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

ODB - General Benefit

bicalutamide

Drugs Used:

bicalutamide

Quick Link(s):

Regimen Monograph

Regimen

BICABSRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

buserelin

ODB - General Benefit

bicalutamide

Drugs Used:

buserelin,

bicalutamide

Quick Link(s):

Regimen Monograph

Oct 2016

Regimen

BSRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

buserelin

Drugs Used:

buserelin

Quick Link(s):

Regimen Monograph

Oct 2016

Regimen

CAPE

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

capecitabine

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jul 2024

Regimen

CAPECISP+TRAS

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

CAPEGEMC

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

gemcitabine,

capecitabine